Functional evaluation of novel single nucleotide polymorphisms and haplotypes in the promoter regions ofCYP1B1 andCYP1A1 genes
- 21 July 2003
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 37 (3), 158-169
- https://doi.org/10.1002/mc.10132
Abstract
Interindividual variation in the expression of the carcinogen- and estrogen-metabolizing enzymes cytochrome P4501B1 and 1A1 (CYP1B1 and CYP1A1) has been detected in human lung. To search for polymorphisms with functional consequences for CYP1B1 and CYP1A1 gene expression, we examined 1.5 kb of the promoter region of each gene. Genomic DNA from 21 Caucasian individuals was amplified by polymerase chain reaction (PCR) for direct cycle sequencing. Eight single nucleotide polymorphisms (SNPs) for CYP1B1 and 13 SNPs for CYP1A1 were found. The majority of polymorphisms occurred as multiSNP combinations for individual subjects. The wild-type sequences were cloned into a luciferase reporter construct. The most frequent polymorphisms were then recreated by iterative site-directed mutagenesis, replicating single polymorphisms and multiSNP combinations. These wild-type and variant constructs were functionally evaluated in transient transfection experiments employing exposures to either the index polycyclic aromatic hydrocarbon (PAH) inducer benzo[a]pyrene (B[a]P), a composite mixture of cigarette smoke extract (CSE), or the repressor chemopreventive agent trans-3,4,5-trihydroxystilbene (reseveratrol). Results indicated that all wild-type and variant constructs responded in qualitatively concordant fashion to the inducers and to the repressor. The CYP1B1 haplotypes and the majority of CYP1A1 haplotypes were shown to have no functional consequence, as compared to those of the wild-type promoter sequences. Two constructs of composite polymorphisms of CYP1A1 appeared to result in a statistically significant increase in basal promoter activity (1.38- and 1.50-fold, respectively), but the degree of functional impact was judged unlikely to be biologically important in vivo. We conclude that the observed promoter region polymorphisms in these genes are common, but are of unclear functional consequence.Keywords
This publication has 33 references indexed in Scilit:
- Lung carcinogenesis: Resveratrol modulates the expression of genes involved in the metabolism of PAH in human bronchial epithelial cellsInternational Journal of Cancer, 2001
- Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purgingBone Marrow Transplantation, 2000
- Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor statusCarcinogenesis: Integrative Cancer Research, 1999
- Resveratrol, a Natural Product Present in Wine, Decreases Tumour Growth in a Rat Tumour ModelBiochemical and Biophysical Research Communications, 1999
- Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from GrapesScience, 1997
- The Molecular Epidemiology of Lung CancerCritical Reviews in Toxicology, 1997
- Correlation between P450 CYP1A1 inducibility, Mspi genotype and lung cancer incidenceEuropean Journal Of Cancer, 1996
- A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphomaCell, 1995
- The ikaros gene is required for the development of all lymphoid lineagesCell, 1994
- Ikaros, an Early Lymphoid-Specific Transcription Factor and a Putative Mediator for T Cell CommitmentScience, 1992